The current study aims to investigate the feasibility of transmitting continuous and wireless vital sign data in real time from patients home to the hospital in patients discharged after an acute medical hospitalization
The healthcare system is challenged by an aging patient population with chronic diseases, and acute admissions must be housed in hospitals with fewer beds and less staff resources. This increases the need for earlier discharge and for treatment shifted to the patients' own home. Furthermore, the transition from the hospital to the home setting is one of potential hazard, due to the lack of observation and intervention possibilities. This study aims to investigate the feasibility of wireless, continuous monitoring of patients in the days around discharge after an acute medical hospitalization, as well as occurrence of deviating vital signs i in the patients' own homes during the first days after discharge. Data will be transmitted continuously in real time from patient's homes to mobile applications for portable handheld devices such as healthcare personnel's smartphones.
Study Type
OBSERVATIONAL
Enrollment
30
Included patients are monitored with WARD equipment during the last part of hospitalization and the first days after discharge with data transmitted in real time to personnel at the hospital. Monitoring will last for a maximum of 72 hours.
Bispebjerg Hospital
Copenhagen, NV, Denmark
Duration of data collection from the Lifetouch patch
Time frame: Up to 72 hours of monitoring
Duration of complete peripheral saturation data
Time frame: Up to 72 hours of monitoring
Duration of complete blood pressure data
Time frame: Up to 72 hours of monitoring
Cummulated duration of desaturation
Peripheral saturation below 88% and 85%
Time frame: Up to 72 hours of monitoring
Number of events with SpO2 < 88% in at least 10 consecutive minutes
Time frame: Up to 72 hours of monitoring
Number of events with SpO2 < 85% in at least 5 consecutive minutes
Time frame: Up to 72 hours of monitoring
Number of deviating vital parameters in accordance to defined microevents
Time frame: Up to 72 hours of monitoring
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.